Henry James International Management Inc.

Position in NVO — Novo Nordisk A S

CIK 1750423 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$2,722,081

+$915,598 QoQ

Shares Held

56,781

+15.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.98%

of 13F equity value

Holder Rank

#319

of 1,348 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Henry James International Management Inc. holds $16,007,752 across 3 Drug Manufacturers - General names. NVO ranks #3 (17.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	36,652	$6,949,952
2	NVS	Novartis AG	40,427	$6,335,719
3	NVO	Novo Nordisk A S This page	56,781	$2,722,081

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,722,081	56,781	+15.5%	Shares	Sole	2026-07-09
2026-03-31	$1,806,483	49,156	-0.1%	Shares	Sole	2026-04-10
2025-12-31	$2,503,346	49,201	-0.0%	Shares	Sole	2026-02-17
2025-09-30	$2,730,662	49,210	0.0%	Shares	Sole	2025-10-27
2025-06-30	$3,396,474	49,210	-5.6%	Shares	Sole	2025-08-14
2025-03-31	$3,618,518	52,110	-0.1%	Shares	Sole	2025-04-25
2024-12-31	$4,485,856	52,149	-0.0%	Shares	Sole	2025-02-05
2024-09-30	$6,210,214	52,156	-6.5%	Shares	Sole	2024-10-30
2024-06-30	$7,959,753	55,764	+3.8%	Shares	Sole	2024-07-12
2024-03-31	$6,900,601	53,743	+14.5%	Shares	Sole	2024-05-08
2023-12-31	$4,856,667	46,947	+0.0%	Shares	Sole	2024-02-06
2023-09-30	$4,269,087	46,944	+842.3%	Shares	Sole	2023-10-26
2023-06-30	$806,237	4,982	+54.1%	Shares	Sole	2023-08-03
2023-03-31	$514,340	3,232	—	Shares	Sole	2023-04-27
No filing history on record for this holder in this stock.